Recurrent pyelonephritis due to NDM-1 metallo-betalactamase producing Pseudomonas aeruginosa in a patient returning from Serbia, France, 2012

Eurosurveillance

Volumn 17, Issue 45, 2012, Pages

  Flateau, C ^a   Janvier, F ^a   Delacour, H ^a   Males, S ^b   Ficko, C ^a   Andriamanantena, D ^a   Jeannot, K ^c   Merens A ^a   Rapp, C ^a  

^a SERVICE D ENDOCRINOLOGIE   (France)

^b CENTRE HOSPITALIER D AVIGNON   (France)

^c UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AZTREONAM; C REACTIVE PROTEIN; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; COLISTIN; CREATININE; DORIPENEM; DOXYCYCLINE; GENTAMICIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; NEW DELHI METALLO BETA LACTAMASE 1; OFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PREDNISOLONE; QUINOLONE DERIVATIVE; RIFAMPICIN; TICARCILLIN; TIGECYCLINE; TIMENTIN; TOBRAMYCIN; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BLADDER CATHETERIZATION; CANCER CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DISK DIFFUSION; DYSURIA; FEMALE; FEVER; FRANCE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PYELONEPHRITIS; RECURRENT DISEASE; SQUAMOUS CELL CARCINOMA; URINALYSIS; VOMITING;

EID: 84869767196     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Haut Conseil de la Santé Publique (HCSP). Maîtrise de la diffusion des bactéries multirésistantes aux antibiotiques importées en France par des patients rapatriés ou ayant des antécédents d'hospitalisation à l'étranger, 2ème version. [Control of the spread of multiresistant bacteria imported in France by repatriated patients or patients previously hospitalised abroad, 2nd version]. Paris: HCSP. Nov 2010. Available from: http://www.hcsp.fr/explore.cgi/ avisrapportsdomaine?clefr=201
2. European Committee on Antimicrobial Susceptibility Testing (EUCAST). EUCAST breakpoint tables for interpretation of MICs and zone diameters, Version 2.0] [Accessed 29 Oct 2012]. Available from: http://www.eucast.org/fileadmin/src/ media/PDFs/EUCAST_files/Breakpoint_tables/Breakpoint_ table_v_2.0_120221.pdf
3. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, et al. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009;53(12):5046-54.
4. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010 Sep;10(9):597-602.
5. Nordmann P, Poirel L, Walsh TR, Livermore DM. The emerging NDM carbapenemases. Trends in microbiology. 2011;19(12):588-95.
6. Struelens MJ, Monnet DL, Magiorakos AP, Santos O'Connor F, Giesecke J, the European NDM-1 Survey Participants. New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe. Euro Surveill. 2010;15(46):pii=19716. Available from: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=19716
7. Bonnin RA, Poirel L, Naas T, Pirs M, Seme K, Schrenzel J, et al. Dissemination of New Delhi metallo-beta-lactamase-1-producing Acinetobacter baumannii in Europe. Clin Microbiol Infect. 2012;18(9):E362-5.
8. Pfeifer Y, Wilharm G, Zander E, Wichelhaus TA, Gottig S, Hunfeld KP, et al. Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007. J Antimicrob Chemother. 2011;66(9):1998-2001.
9. Livermore DM, Walsh TR, Toleman M, Woodford N. Balkan NDM-1: escape or transplant? Lancet Infect Dis. 2011;11(3):164.
10. Jovcic B, Lepsanovic Z, Suljagic V, Rackov G, Begovic J, Topisirovic L, et al. Emergence of NDM-1 metallo-betalactamase in Pseudomonas aeruginosa clinical isolates from Serbia. Antimicrob Agents Chemother. 2011;55(8):3929-31.
11. Moriyama B, Henning SA, Childs R, Holland SM, Anderson VL, Morris JC, et al. High-dose continuous infusion betalactam antibiotics for the treatment of resistant Pseudomonas aeruginosa infections in immunocompromised patients. Ann Pharmacother. 2010;44(5):929-35.
12. Prevotat A, Leroy S, Perez T, Wallet F, Wallaert B. [Tolerance and efficacy of ceftazidime in combination with aztreonam for exacerbations of cystic fibrosis]. Rev Mal Respir. 2010;27(5):449-56.
13. Cholley P, Thouverez M, Hocquet D, van der Mee-Marquet N, Talon D, Bertrand X. Most multidrug-resistant Pseudomonas aeruginosa isolates from hospitals in eastern France belong to a few clonal types. J Clin Microbiol. 2011;49(7):2578-83.
14. Garcia-Castillo M, Del Campo R, Morosini MI, Riera E, Cabot G, Willems R, et al. Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals. J Clin Microbiol. 2011;49(8):2905-10.